抗抑郁药治疗中抑郁症状的网络动力学:八项临床试验的二次分析
该研究汇总八项安慰剂对照试验(n=3559)的HAMD-17数据,比较活性抗抑郁药与安慰剂下症状改善的网络关联。时滞纵向分析显示,在抗抑郁药条件下,抑郁心境、失眠和自杀意念的改善对后续其他症状改善影响更广,且抑郁心境和失眠改善更易跟随其他症状改善。
要点
- 抗抑郁药治疗中抑郁心境、失眠和自杀意念的改善对后续其他症状改善影响更广。
- 抗抑郁药治疗中抑郁心境和失眠的改善更易跟随其他症状改善。
- 上述三个症状可能在抗抑郁药治疗缓解与康复中尤为重要。
核心结论
- 在抗抑郁药治疗条件下,抑郁心境、失眠和自杀意念的改善对后续其他抑郁症状改善具有更广的总体影响。
- 抑郁心境和失眠的改善在抗抑郁药条件下更易跟随其他症状的改善。
研究设计与样本
- 汇总八项由企业资助的安慰剂对照试验的前瞻性数据,涵盖帕罗西汀、氟西汀和丙咪嗪,总样本量n=3559。
- 采用17项汉密尔顿抑郁量表评估抑郁症状,将治疗二分为活性抗抑郁药治疗与安慰剂。
- 使用时滞纵向分析比较活性药物与安慰剂条件下症状改善的网络关联。
主要发现
- 与安慰剂相比,活性抗抑郁药条件下抑郁心境、失眠和自杀意念的改善对后续其他抑郁症状改善的总体影响更广(out-strength更高)。
- 与安慰剂相比,活性抗抑郁药条件下抑郁心境和失眠的改善更易跟随其他症状的改善(in-strength更高)。
临床怎么用
- 临床中可关注抑郁心境、失眠和自杀意念的早期改善,因其可能对后续其他症状改善有更广影响。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Depression can be viewed as a network of depressive symptoms that tend to reinforce each other via feedback loops. Specific symptoms of depression may be differently responsive to antidepressant treatment, and some symptoms may be more important than others in the overall improvement of depression associated with treatment. We pooled prospective data from eight industry-sponsored placebo-controlled trials for paroxetine, fluoxetine and imipramine (total n = 3559) to examine whether improvements in specific depressive symptoms were more strongly related to improvements in other depressive symptoms among patients on active antidepressant treatment as compared to placebo. Depressive symptoms were assessed with the 17-item Hamilton Depression Rating Scale. Data on treatment was dichotomized into active treatment (receiving any antidepressant agent) vs. placebo. Time-lagged longitudinal analyses suggested that improvement in three symptoms-depressed mood, insomnia, and suicidality-had a broader overall impact on subsequent improvement in other depressive symptoms in the antidepressant condition compared to placebo (i.e., greater out-strength). Moreover, improvements in depressed mood and insomnia were more likely to follow the improvements in other symptoms in the antidepressant condition compared to placebo (i.e., greater in-strength). These results from clinical trial data suggest that depressed mood, insomnia, and suicidality may be particularly important in accounting for the remission and recovery in response to antidepressant treatment.
引用
- Komulainen K, Airaksinen J, Savelieva K, et al. Network dynamics of depressive symptoms in antidepressant medication treatment: secondary analysis of eight clinical trials. Mol Psychiatry. 2020. PMID: 32939019. doi:10.1038/s41380-020-00884-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。